Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HUM2N, formerly known as MIH Clinic (Modern Integrative Health), is a London-based healthcare company specializing in longevity, regenerative medicine, and personalized wellness. The company operates advanced clinical facilities that offer a range of bio-optimization treatments, including intravenous (IV) nutrient therapy, bio-identical hormone replacement therapy (BHRT), and hyperbaric oxygen therapy. HUM2N focuses on a data-driven approach to health, utilizing comprehensive functional testing to create individualized protocols aimed at extending healthspan and optimizing physical and cognitive performance. The clinic is a prominent player in the growing longevity healthcare sector, catering to individuals seeking proactive and preventative medical care. By integrating cutting-edge medical technology with holistic health strategies, HUM2N aims to redefine the standard of preventative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MIH Clinic.